Improving RNA sequencing accuracy using a novel method
Twice reading of RNA by direct nanopore sequencing
This study is testing a new way to read RNA more accurately using a special technique that could help us better understand how genes work, which might lead to better tests and treatments for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Thomas Jefferson University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11081654 on NIH RePORTER |
What this research studies
This research focuses on enhancing the accuracy of RNA sequencing by employing a technique called 'twice reading' using a specialized enzyme from the poliovirus. By copying RNA modifications twice, the study aims to provide a more precise mapping of these modifications, which are crucial for understanding gene expression and their roles in health and disease. The approach utilizes advanced nanopore sequencing technology to capture and quantify RNA modifications that are often missed in traditional methods. Patients may benefit from improved diagnostic tools and treatments based on a better understanding of RNA modifications.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions related to gene expression and RNA modifications, such as certain cancers or genetic disorders.
Not a fit: Patients with conditions unrelated to RNA modifications or those who do not have any genetic disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnostics and targeted therapies for diseases influenced by RNA modifications.
How similar studies have performed: Previous research has shown promise in improving RNA sequencing techniques, but this specific approach of 'twice reading' is relatively novel and untested.
Where this research is happening
Philadelphia, United States
- Thomas Jefferson University — Philadelphia, United States (Active)
Researchers
- Principal investigator: Hou, Ya-Ming — Thomas Jefferson University
- Study coordinator: Hou, Ya-Ming
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.